Literature DB >> 9703890

Glioma cell adhesion and migration on human brain sections.

A Giese1, B Laube, S Zapf, U Mangold, M Westphal.   

Abstract

Within the brain, dissemination of glioma cells follows myelinated fiber tracts and extracellular matrix containing structures such as the basement membranes of blood vessels. These patterns represent the two major routes of invasion frequently observed in clinical disease. Previously, we have characterized the substrates for preferential glioma adhesion and migration on purified ECM protein. In this study sections of human brain from different anatomical regions were used as adhesive substrates and also characterized for the presence and distribution of matrix proteins. Adhesion of marker gene transfected glioma cell suspensions to different regions and anatomical structures of human brain was quantified using a computer assisted image analysis system. Monoclonal antibodies against different adhesion molecules were used to inhibit glioma cell attachment ot specific anatomical structures. In addition, glioma cell aggregates were allowed to adhere to brain sections and single cells were observed to migrate out of these aggregates. Scanning electron microscopy was used to morphologically study the preferred routes of glioma dissemination on brain sections. In brain sections different kinetics of cell adhesion to distinct structures were observed. Within 15 minutes cells adhered and spread on blood vessels and arachnoid tissue containing sections. Choroid plexus and the ventricular wall were also adhesive structures. Adhesion to cortex required 1 hour, while adhesion and spreading on myelinated fiber tracts was retarded and required several hours of incubation. The predominant matrix proteins in small vessels were found to be laminin, collagen type IV, and fibronectin. Choroid plexus and the ependyma showed a similar composition of matrix proteins. Arachnoid fibers contained different types of collagens, predominately type I and III, whereas the only matrix protein identified in the subependyma was fibronectin. Antibodies to the alpha 2, alpha 3, and beta 1 integrin subunits completely blocked adhesion to arachnoid tissue, anti-NCAM inhibited attachment to cortex. Adhesion to blood vessels in brain sections could only be inhibited to 50% by anti-integrin beta 1. Antibodies to the av containing integrin av beta 3 also blocked 50% of adhesion to vessels. Our findings indicate that adhesion of glioma cells to brain sections most rapidly takes place on ECM protein containing regions, especially blood vessels which may serve as guiding structures for glioma dissemination.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703890

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

Review 1.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  The brain slice chamber, a novel variation of the Boyden Chamber Assay, allows time-dependent quantification of glioma invasion into mammalian brain in vitro.

Authors:  Christian Schichor; Siglinde Kerkau; Theresa Visted; Rudolf Martini; Rolf Bjerkvig; Jörg Christian Tonn; Roland Goldbrunner
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

3.  Regulation of glioma cell migration by serine-phosphorylated P311.

Authors:  Wendy S McDonough; Nhan L Tran; Michael E Berens
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

4.  AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.

Authors:  Yuji Piao; Li Lu; John de Groot
Journal:  Neuro Oncol       Date:  2008-10-28       Impact factor: 12.300

5.  Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases.

Authors:  Dieta Brandsma; Laurien Ulfman; Jaap C Reijneveld; Madelon Bracke; Martin J B Taphoorn; Jaap Jan Zwaginga; Martijn F B Gebbink; Hetty de Boer; Leo Koenderman; Emile E Voest
Journal:  Neuro Oncol       Date:  2006-03-13       Impact factor: 12.300

6.  Mesenchymal migration as a therapeutic target in glioblastoma.

Authors:  Jessie Zhong; Andre Paul; Stewart J Kellie; Geraldine M O'Neill
Journal:  J Oncol       Date:  2010-06-21       Impact factor: 4.375

7.  Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model.

Authors:  Christina H Wang; Jason K Rockhill; Maciej Mrugala; Danielle L Peacock; Albert Lai; Katy Jusenius; Joanna M Wardlaw; Timothy Cloughesy; Alexander M Spence; Russ Rockne; Ellsworth C Alvord; Kristin R Swanson
Journal:  Cancer Res       Date:  2009-11-24       Impact factor: 12.701

Review 8.  Identifying new small molecule anti-invasive compounds for glioma treatment.

Authors:  Jennifer Munson; Michael Bonner; Levi Fried; Jonathan Hofmekler; Jack Arbiser; Ravi Bellamkonda
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

9.  Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas.

Authors:  Matija Snuderl; Susan N Chi; Stacia M De Santis; Anat O Stemmer-Rachamimov; Rebecca A Betensky; Umberto De Girolami; Mark W Kieran
Journal:  J Neuropathol Exp Neurol       Date:  2008-09       Impact factor: 3.685

10.  Ependymal enhancement on magnetic resonance imaging for the identification of high-grade gliomas.

Authors:  Muhammad Waqas; Muzna Iftikhar; Usman T Siddiqui; Syed Ather Enam
Journal:  Surg Neurol Int       Date:  2017-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.